Does methamphetamine affect bone metabolism?
Autor: | Shigeko Fushimi, Hironobu Katsuyama, Masayuki Nata, Yoko Watanabe, Takaki Ishikawa, Osamu Miyamoto, Toshiko Okuyama, Masafumi Tomita |
---|---|
Rok vydání: | 2014 |
Předmět: |
Male
medicine.medical_specialty Acid Phosphatase Osteocalcin Osteoporosis Toxicology Bone resorption Methamphetamine Bone remodeling Mice chemistry.chemical_compound Bone Density Internal medicine medicine Animals Femur Bone mineral biology Tartrate-Resistant Acid Phosphatase Chemistry Phosphorus Blood Proteins Meth Alkaline Phosphatase medicine.disease Isoenzymes Mice Inbred C57BL medicine.anatomical_structure Endocrinology Biochemistry biology.protein Alkaline phosphatase Calcium Central Nervous System Stimulants Bone Remodeling Cancellous bone |
Zdroj: | Toxicology. 319:63-68 |
ISSN: | 0300-483X |
DOI: | 10.1016/j.tox.2014.01.014 |
Popis: | There is a close relationship between the central nervous system activity and bone metabolism. Therefore, methamphetamine (METH), which stimulates the central nervous system, is expected to affect bone turnover. The aim of this study was to investigate the role of METH in bone metabolism. Mice were divided into 3 groups, the control group receiving saline injections, and the 5 and 10mg/kg METH groups (n=6 in each group). All groups received an injection of saline or METH every other day for 8 weeks. Bone mineral density (BMD) was assessed by X-ray computed tomography. We examined biochemical markers and histomorphometric changes in the second cancellous bone of the left femoral distal end. The animals that were administered 5mg/kg METH showed an increased locomotor activity, whereas those receiving 10mg/kg displayed an abnormal and stereotyped behavior. Serum calcium and phosphorus concentrations were normal compared to the controls, whereas the serum protein concentration was lower in the METH groups. BMD was unchanged in all groups. Bone formation markers such as alkaline phosphatase and osteocalcin significantly increased in the 5mg/kg METH group, but not in the 10mg/kg METH group. In contrast, bone resorption markers such as C-terminal telopeptides of type I collagen and tartrate-resistant acid phosphatase 5b did not change in any of the METH groups. Histomorphometric analyses were consistent with the biochemical markers data. A significant increase in osteoblasts, especially in type III osteoblasts, was observed in the 5mg/kg METH group, whereas other parameters of bone resorption and mineralization remained unchanged. These results indicate that bone remodeling in this group was unbalanced. In contrast, in the 10mg/kg METH group, some parameters of bone formation were significantly or slightly decreased, suggesting a low turnover metabolism. Taken together, our results suggest that METH had distinct dose-dependent effects on bone turnover and that METH might induce adverse effects, leading to osteoporosis. |
Databáze: | OpenAIRE |
Externí odkaz: |